Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Repurchased
Ratios

Corcept Therapeutics (CORT) Long-Term Debt Repayments: 2011-2017

Historic Long-Term Debt Repayments for Corcept Therapeutics (CORT) over the last 1 years, with Sep 2017 value amounting to $4.6 million.

  • Corcept Therapeutics' Long-Term Debt Repayments was N/A to $4.6 million in Q3 2017 from the same period last year, while for Sep 2017 it was $19.6 million, marking a year-over-year change of. This contributed to the annual value of $15.1 million for FY2017, which is 2.40% up from last year.
  • According to the latest figures from Q3 2017, Corcept Therapeutics' Long-Term Debt Repayments is $4.6 million, which was down 18.91% from $5.7 million recorded in Q2 2017.
  • Corcept Therapeutics' 5-year Long-Term Debt Repayments high stood at $5.7 million for Q2 2017, and its period low was $3.0 million during Q1 2016.
  • Over the past 2 years, Corcept Therapeutics' median Long-Term Debt Repayments value was $4.6 million (recorded in 2017), while the average stood at $4.5 million.
  • Data for Corcept Therapeutics' Long-Term Debt Repayments shows a peak YoY skyrocketed of 58.90% (in 2017) over the last 5 years.
  • Over the past 2 years, Corcept Therapeutics' Long-Term Debt Repayments (Quarterly) stood at $4.4 million in 2016, then surged by 58.90% to $4.6 million in 2017.
  • Its Long-Term Debt Repayments stands at $4.6 million for Q3 2017, versus $5.7 million for Q2 2017 and $4.8 million for Q1 2017.